SEC Form 4 · accession 0001555280-19-000111
Zoetis Inc. · ZTS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Roman Trawicki
Officer — Executive Vice President
Period of report
Mar 1, 2019
Accepted (ET)
Mar 5, 2019 · 4:20 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001555280
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 1, 2019 | M | 17,873 | $41.83 | A | 24,772 | D | |
| Common StockF1 | Mar 1, 2019 | S | 17,873 | $95.10 | D | 6,899 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionF2,F6,F3,F4,F5 | — | Mar 1, 2019 | M | 17,873 | D | — | — | Common Stock | 17,873 | 43,233 | D |
Explanation of responses
- F1The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.00 to $95.13, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F2Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant.
- F317,873 options granted February 19, 2016 at an exercise price of $41.83 per option.
- F4Each option vests on the third anniversary of the date of grant.
- F5Each option expires on the tenth anniversary of the date of grant.
- F616,317 options granted February 14, 2017 at an exercise price of $55.02 per option; 13,142 options granted February 13, 2018 at an exercise price of $73.24 per option; and 13,774 options granted February 12, 2019 at an exercise price of $87.51.